Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Balance Sheet

Financials in millions GBP. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1.04	0.36	1.2	0.2	2.05
Cash & Short-Term Investments	1.04	0.36	1.2	0.2	2.05
Cash Growth	190.53%	-70.06%	514.87%	-90.48%	-23.72%
Accounts Receivable	0.53	0.33	0.44	0.36	0.78
Other Receivables	0.18	0.16	0.05	0.34	0.25
Receivables	0.71	0.49	0.49	0.7	1.02
Inventory	0.36	0.27	0.46	0.54	0.59
Prepaid Expenses	0.26	0.23	0.11	0.26	0.62
Total Current Assets	2.37	1.35	2.26	1.69	4.28
Property, Plant & Equipment	0.36	0.06	0.16	0.38	0.63
Total Assets	2.73	1.41	2.42	2.06	4.92

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	0.49	0.37	0.56	0.48	0.47
Accrued Expenses	0.23	0.21	-	0.31	0.63
Current Portion of Leases	0.1	0.02	0.02	0.04	0.07
Other Current Liabilities	0.02	0.02	-	0.05	0.05
Total Current Liabilities	0.84	0.62	0.58	0.88	1.21
Long-Term Debt	0.23	-	-	-	-
Long-Term Leases	-	-	0.02	0.04	0
Other Long-Term Liabilities	0.03	0.03	0.02	0.02	0.02
Total Liabilities	1.1	0.65	0.63	0.94	1.23

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	5	4.2	3.82	1.04	1.04
Additional Paid-In Capital	9.12	7.94	7.74	7.65	7.65
Retained Earnings	-12.5	-11.38	-9.77	-7.56	-5
Shareholders' Equity	1.62	0.76	1.79	1.12	3.68
Total Liabilities & Equity	2.73	1.41	2.42	2.06	4.92

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.33	0.02	0.04	0.08	0.07
Net Cash (Debt)	0.71	0.34	1.16	0.12	1.98
Net Cash Growth	110.03%	-70.67%	863.33%	-93.94%	-19.38%
Net Cash Per Share	0.01	0.00	0.02	0.00	0.08
Filing Date Shares Outstanding	125.02	104.9	95.37	26.01	26.01
Total Common Shares Outstanding	125.02	104.9	95.37	26.01	26.01
Working Capital	1.53	0.72	1.68	0.81	3.07
Book Value Per Share	0.01	0.01	0.02	0.04	0.14
Tangible Book Value	1.62	0.76	1.79	1.12	3.68
Tangible Book Value Per Share	0.01	0.01	0.02	0.04	0.14
Machinery	2.75	2.68	2.68	2.67	2.66
Leasehold Improvements	0.84	0.84	0.84	0.84	0.81

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 25, 2026

Data Sources Report a data error